| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
8,043 |
6,318 |
$285K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,124 |
4,478 |
$284K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,226 |
1,178 |
$77K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,280 |
1,136 |
$66K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,865 |
1,605 |
$22K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,992 |
1,717 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,632 |
1,960 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
49 |
37 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
102 |
88 |
$789.18 |
| 81003 |
|
340 |
309 |
$466.10 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
20 |
19 |
$0.00 |